Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methotrexate Polyglutamates as a Marker of Clinical Response and Toxicity in the Treatment of Psoriasis

NCT02174354 is registered in ClinicalTrials.gov with King's College London as lead sponsor.

NCT NCT02174354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02174354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methotrexate Polyglutamates as a Marker of Clinical Response and Toxicity in the Treatment of Psoriasis
Lead sponsor
King's College London
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2011
Completion date
August 31, 2018
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

injury of liver, psoriasis chronic